Terms: = Germ cell tumor AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Prognosis
201 results:
1. KIAA0040 enhances glioma growth by controlling the JAK2/stat3 signalling pathway.
He J; Xue K; Fan F; Li L; Rao X; Liu W; Nie C
J Cell Mol Med; 2024 Apr; 28(8):e18332. PubMed ID: 38661644
[TBL] [Abstract] [Full Text] [Related]
2. Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/stat3 axis.
Qiu Y; Pei D; Wang M; Wang Q; Duan W; Wang L; Liu K; Guo Y; Luo L; Guo Z; Guan F; Wang Z; Xing A; Liu Z; Ma Z; Jiang G; Yan D; Liu X; Zhang Z; Wang W
CNS Neurosci Ther; 2024 Apr; 30(4):e14709. PubMed ID: 38605477
[TBL] [Abstract] [Full Text] [Related]
3. Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.
Jin X; Zhu J; Yu H; Shi S; Shen K; Gu J; Yin Z; Yu Z; Wu J
PLoS One; 2024; 19(3):e0298055. PubMed ID: 38530810
[TBL] [Abstract] [Full Text] [Related]
4. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
[TBL] [Abstract] [Full Text] [Related]
5. ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating stat3 phosphorylation.
Zhang J; Li R; Zhang H; Wang S; Zhao Y
Carcinogenesis; 2024 Apr; 45(4):235-246. PubMed ID: 38142122
[TBL] [Abstract] [Full Text] [Related]
6. The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery.
Yue C; Lian W; Duan M; Xia D; Cao X; Peng J
Environ Toxicol; 2024 Mar; 39(3):1858-1873. PubMed ID: 38140739
[TBL] [Abstract] [Full Text] [Related]
7. REC8 regulates neuroblastoma cell proliferation, migration, invasion, and angiogenesis via stat3/VEGF signaling.
Wang Q; Fan W; Hao Z; Liang B; Fan M; Zhao Z; Li Z
J Egypt Natl Canc Inst; 2023 Dec; 35(1):41. PubMed ID: 38105365
[TBL] [Abstract] [Full Text] [Related]
8. RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating stat3 in glioblastoma.
Chen Y; Mu Y; Guan Q; Li C; Zhang Y; Xu Y; Zhou C; Guo Y; Ma Y; Zhao M; Ji G; Liu P; Sun D; Sun H; Wu N; Jin Y
Cell Death Dis; 2023 Nov; 14(11):757. PubMed ID: 37985768
[TBL] [Abstract] [Full Text] [Related]
9. KIF22 promotes the proliferation and glycolysis of melanoma by activating EGFR/stat3 signaling.
Zhong Z; Zhong H
Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
[TBL] [Abstract] [Full Text] [Related]
10. CTSC promoted the migration and invasion of glioma cells via activation of stat3/SERPINA3 axis.
Li Q; Wan C; Zhang Z; Liu G; Wang S
Gene; 2024 Jan; 893():147948. PubMed ID: 37925117
[TBL] [Abstract] [Full Text] [Related]
11. Multi-Omics Analyses Reveal Mitochondrial Dysfunction Contributing to Temozolomide Resistance in Glioblastoma cells.
Zhang H; Chen Y; Liu X; Deng H
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759808
[TBL] [Abstract] [Full Text] [Related]
12. Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma.
Pang F; Zhang L; Li M; Yi X; Wang Y; Yang P; Wen B; Jiang J; Teng Y; Yang X; Chen L; Xu J; Wang L
Cancer Gene Ther; 2023 Dec; 30(12):1636-1648. PubMed ID: 37726387
[TBL] [Abstract] [Full Text] [Related]
13. tumor-associated astrocytes promote tumor progression of Sonic Hedgehog medulloblastoma by secreting lipocalin-2.
Li H; Liu Y; Liu Y; Xu L; Sun Z; Zheng D; Liu X; Song C; Zhang Y; Liang H; Yang B; Tian X; Luo J; Chang Q
Brain Pathol; 2024 Jan; 34(1):e13212. PubMed ID: 37721122
[TBL] [Abstract] [Full Text] [Related]
14. Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma.
Pang L; Dunterman M; Guo S; Khan F; Liu Y; Taefi E; Bahrami A; Geula C; Hsu WH; Horbinski C; James CD; Chen P
Nat Immunol; 2023 Oct; 24(10):1654-1670. PubMed ID: 37667051
[TBL] [Abstract] [Full Text] [Related]
15. Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway.
Zhao G; Deng Z; Li X; Wang H; Chen G; Feng M; Zhou Y
Exp Brain Res; 2023 Oct; 241(10):2409-2418. PubMed ID: 37644332
[TBL] [Abstract] [Full Text] [Related]
16. A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P
Bergkamp ND; van Senten JR; Brink HJ; Bebelman MP; van den Bor J; Çobanoğlu TS; Dinkla K; Köster J; Klau G; Siderius M; Smit MJ
Sci Signal; 2023 Aug; 16(798):eade6737. PubMed ID: 37582160
[TBL] [Abstract] [Full Text] [Related]
17. ANXA1 Promotes tumor Immune Evasion by Binding PARP1 and Upregulating stat3-Induced Expression of PD-L1 in Multiple Cancers.
Xiao D; Zeng T; Zhu W; Yu ZZ; Huang W; Yi H; Lu SS; Feng J; Feng XP; Wu D; Wen Q; Zhou JH; Yuan L; Zhuang W; Xiao ZQ
Cancer Immunol Res; 2023 Oct; 11(10):1367-1383. PubMed ID: 37566399
[TBL] [Abstract] [Full Text] [Related]
18. Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program.
Park J; Shim JK; Lee M; Kim D; Yoon SJ; Moon JH; Kim EH; Park JY; Chang JH; Kang SG
Br J Cancer; 2023 Oct; 129(7):1061-1070. PubMed ID: 37558923
[TBL] [Abstract] [Full Text] [Related]
19. Eukaryotic initiation factor 4 A-3 promotes glioblastoma growth and invasion through the Notch1-dependent pathway.
Wei L; Pan M; Jiang Q; Hu B; Zhao J; Zou C; Chen L; Tang C; Zou D
BMC Cancer; 2023 Jun; 23(1):550. PubMed ID: 37322413
[TBL] [Abstract] [Full Text] [Related]
20. Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma.
Dai L; Han Y; Yang Z; Zeng Y; Liang W; Shi Z; Tao Y; Liang X; Liu W; Zhou S; Xing Z; Hu W; Wang X
J Cell Mol Med; 2023 Aug; 27(15):2194-2214. PubMed ID: 37315184
[TBL] [Abstract] [Full Text] [Related]
[Next]
